JP2016506948A5 - - Google Patents

Download PDF

Info

Publication number
JP2016506948A5
JP2016506948A5 JP2015555863A JP2015555863A JP2016506948A5 JP 2016506948 A5 JP2016506948 A5 JP 2016506948A5 JP 2015555863 A JP2015555863 A JP 2015555863A JP 2015555863 A JP2015555863 A JP 2015555863A JP 2016506948 A5 JP2016506948 A5 JP 2016506948A5
Authority
JP
Japan
Prior art keywords
methacrylic acid
acid copolymer
solid dispersion
pharmaceutical composition
cilostazol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015555863A
Other languages
English (en)
Japanese (ja)
Other versions
JP5980449B2 (ja
JP2016506948A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2015555863A priority Critical patent/JP5980449B2/ja
Priority claimed from JP2015555863A external-priority patent/JP5980449B2/ja
Publication of JP2016506948A publication Critical patent/JP2016506948A/ja
Publication of JP2016506948A5 publication Critical patent/JP2016506948A5/ja
Application granted granted Critical
Publication of JP5980449B2 publication Critical patent/JP5980449B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015555863A 2013-02-06 2014-02-05 非晶質なシロスタゾールを含有する固体分散体 Expired - Fee Related JP5980449B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2015555863A JP5980449B2 (ja) 2013-02-06 2014-02-05 非晶質なシロスタゾールを含有する固体分散体

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2013021475 2013-02-06
JP2013021475 2013-02-06
JP2015555863A JP5980449B2 (ja) 2013-02-06 2014-02-05 非晶質なシロスタゾールを含有する固体分散体
PCT/JP2014/053232 WO2014123244A1 (en) 2013-02-06 2014-02-05 Solid dispersion comprising amorphous cilostazol

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016102975A Division JP2016193915A (ja) 2013-02-06 2016-05-24 非晶質なシロスタゾールを含有する固体分散体

Publications (3)

Publication Number Publication Date
JP2016506948A JP2016506948A (ja) 2016-03-07
JP2016506948A5 true JP2016506948A5 (enExample) 2016-04-14
JP5980449B2 JP5980449B2 (ja) 2016-08-31

Family

ID=50184966

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2015555863A Expired - Fee Related JP5980449B2 (ja) 2013-02-06 2014-02-05 非晶質なシロスタゾールを含有する固体分散体
JP2016102975A Pending JP2016193915A (ja) 2013-02-06 2016-05-24 非晶質なシロスタゾールを含有する固体分散体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016102975A Pending JP2016193915A (ja) 2013-02-06 2016-05-24 非晶質なシロスタゾールを含有する固体分散体

Country Status (11)

Country Link
US (1) US9555026B2 (enExample)
EP (1) EP2953615B1 (enExample)
JP (2) JP5980449B2 (enExample)
KR (1) KR102205192B1 (enExample)
CN (1) CN105050586B (enExample)
AR (1) AR095143A1 (enExample)
AU (1) AU2014215920B2 (enExample)
CA (1) CA2899389C (enExample)
PH (1) PH12015501722B1 (enExample)
TW (1) TWI615157B (enExample)
WO (1) WO2014123244A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018146551A2 (en) * 2017-02-10 2018-08-16 Lexi Pharma Inc. Compositions of gallium (iii) complexes for oral administration
KR102114550B1 (ko) * 2018-07-10 2020-05-22 삼육대학교산학협력단 생리학적 체내 동태 연구 모델링을 이용한 약제학적 조성물의 제조 방법
US20200345645A1 (en) * 2019-05-03 2020-11-05 Azora Therapeutics, Inc. Compositions comprising indigo and/or an indigo derivative and methods of use thereof

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0559911B1 (en) 1991-10-01 1997-11-26 Otsuka Pharmaceutical Factory, Inc. Antithrombotic resin, tube, film and coating
JP3799093B2 (ja) * 1995-01-10 2006-07-19 大塚製薬株式会社 樹脂粒状物およびこれを含有する医療製剤
AU4357096A (en) * 1995-01-10 1996-07-31 Otsuka Pharmaceutical Co., Ltd. Resin particle, medical material and pharmaceutical preparation containing said resin particle
DE69628276T2 (de) 1995-07-26 2004-04-08 Kyowa Hakko Kogyo Co., Ltd. Zubereitung von xanthinderivaten als feste dispersion
JPH11246404A (ja) 1998-03-04 1999-09-14 Taiho Yakuhin Kogyo Kk 吸収を改善した医薬組成物
US6350786B1 (en) 1998-09-22 2002-02-26 Hoffmann-La Roche Inc. Stable complexes of poorly soluble compounds in ionic polymers
JP4748839B2 (ja) 1999-03-25 2011-08-17 大塚製薬株式会社 シロスタゾール製剤
EG23951A (en) 1999-03-25 2008-01-29 Otsuka Pharma Co Ltd Cilostazol preparation
JP2006513186A (ja) * 2002-12-20 2006-04-20 ファイザー・プロダクツ・インク Cetp阻害剤およびhmg−coaレダクターゼ阻害剤を含む剤形
CN1241566C (zh) * 2004-03-15 2006-02-15 深圳海王药业有限公司 西洛他唑固体分散体及其片剂制备方法
JP2008521878A (ja) * 2004-12-02 2008-06-26 ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー 非晶質アトルバスタチンの医薬組成物及びその製造のための方法
BRPI0620271A2 (pt) * 2005-12-22 2011-11-08 Otsuka Pharma Co Ltd preparado com liberação sustentada contendo gránulos e método para produção do mesmo
US20100172989A1 (en) * 2006-01-21 2010-07-08 Abbott Laboratories Abuse resistant melt extruded formulation having reduced alcohol interaction
JP2007308480A (ja) * 2006-04-20 2007-11-29 Shin Etsu Chem Co Ltd 腸溶性固体分散体を含んでなる固形製剤
US20110165236A1 (en) * 2006-09-22 2011-07-07 Biokey, Inc. Controlled release hydrogel formulation
KR20080076440A (ko) * 2007-02-16 2008-08-20 (주)아모레퍼시픽 실로스타졸의 제어방출 제제 및 그 제조방법
JP2010526848A (ja) 2007-05-11 2010-08-05 エフ.ホフマン−ラ ロシュ アーゲー 難溶性薬物用の医薬組成物
US9072670B2 (en) 2007-10-19 2015-07-07 Otsuka Pharmaceutical Co., Ltd. Matrix-type pharmaceutical solid preparation
AR071706A1 (es) * 2008-05-15 2010-07-07 Otsuka Pharma Co Ltd Una formulacion farmaceutica de cilostazol solida de liberacion sostenida y metodo de preparacion.
TW201010743A (en) * 2008-09-05 2010-03-16 Otsuka Pharma Co Ltd Pharmaceutical solid preparation
WO2011027656A1 (en) 2009-09-04 2011-03-10 Semiconductor Energy Laboratory Co., Ltd. Transistor and display device
KR101282847B1 (ko) * 2011-07-27 2013-07-05 조선대학교산학협력단 실로스타졸을 함유하는 고체분산체 및 이를 포함하는 약학 조성물

Similar Documents

Publication Publication Date Title
JP2015078220A5 (enExample)
JP2016506948A5 (enExample)
HK1209371A1 (en) Oral and/or buccal composition in the form of a thin film of a weakly soluble active ingredient, method of preparing same and use of same
EP3219311A4 (en) Pharmaceutical composition comprising dabigatran etexilate, and preparation method, solid preparation and use thereof
WO2016008401A8 (zh) 一种含多西他赛的药物组合物
WO2014184663A3 (en) Orally dispersible drug formulations
CN302073115S (zh) 空心矩形桩(h型)
CN302073140S (zh) 空心矩形桩(工字形)
WO2014141298A3 (en) Stable pharmaceutical composition of fingolimod
CN302453975S (zh) 米袋(康盈金山水)
CN302277415S (zh) 包装盒(醋酸地塞米松片)
CN302428423S (zh) 瓶子(4)
CN302537025S (zh) 护栏(02)
CN302241146S (zh) 包装袋(电池级碳酸锂1)
CN302524919S (zh) 包装瓶(蜂王浆冻干片)
CN302277697S (zh) 包装袋(吲哚美辛巴布膏)
CN301997976S (zh) 资料袋(3)
CN302277289S (zh) 药品包装盒(伲福达)
CN302277416S (zh) 包装盒(醋酸泼尼松片 百片)
CN302332132S (zh) 包装袋(阿苯达唑伊维菌素预混剂)
CN301997974S (zh) 资料袋(1)
CN302241141S (zh) 包装袋(工业二级碳酸锂1)
CN302241145S (zh) 包装袋(工业级单水氢氧化锂2)
CN302422314S (zh) 包装袋(植物及介质融合图)
CN302423287S (zh) 带套管结构的熔断器